Werewolf Therapeutics, Inc. · NASDAQ:HOWL
Luke Evnin sold 105,565 Werewolf Therapeutics, Inc. shares (Form 4)
Traded Jun 4 to Jun 8, 2026 · Filed Jun 8, 2026
From Jun 4 to Jun 8, 2026, Luke Evnin (Director) sold 105,565 Werewolf Therapeutics, Inc. shares at an average US$0.41 for US$43,029 under a trading plan, leaving 377,211 shares. Filed Jun 8, 2026 (Form 4).
- Sold
- 105,565 shares
- Price
- US$0.41 average (US$0.40 to US$0.44)
- Value
- US$43,029
- Holding after
- 377,211 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | Sale | 20,072 | US$0.44 | 462,704 | Indirect |
| Jun 5, 2026 | Common Stock | Sale | 24,946 | US$0.40 | 437,758 | Indirect |
| Jun 8, 2026 | Common Stock | Sale | 60,547 | US$0.40 | 377,211 | Indirect |
Source
Related
- Werewolf Therapeutics, Inc.
- Luke Evnin
- Werewolf Therapeutics, Inc. shareholders
- Form 4 · Luke Evnin · Jul 8, 2026
- Form 4 · Luke Evnin · Jun 29, 2026
- Form 4 · Luke Evnin · Jun 10, 2026
- Form 4 · Luke Evnin · Jun 3, 2026
- Form 4 · Luke Evnin · May 29, 2026
- Schedule 13G · Moll Peter · Sep 21, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 2, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 26, 2026
- Form 4 · Ra Capital Management, L.P. · Jun 22, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 22, 2026